|
|
Postgrad Med J. 1985 September; 61(719): 773–778. | PMCID: PMC2418377 |
The effects of treatment on target organ damage in hypertensive disease. J. Lowenstein Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1018K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Azar S, Tobian L, Johnson MA. Glomerular, efferent arteriolar, peritubular capillary, and tubular pressures in hypertension. Am J Physiol. 1974 Nov;227(5):1045–1050. [PubMed]
- Ballantyne D, Ballantyne FC. Thiazides, beta blockers and lipoproteins. Postgrad Med J. 1983 Aug;59(694):483–488. [PubMed]
- BYROM FB. The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension; experimental evidence from the hypertensive rat. Lancet. 1954 Jul 31;267(6831):201–211. [PubMed]
- ENOS WF, Jr, BEYER JC, HOLMES RH. Pathogenesis of coronary disease in American soldiers killed in Korea. J Am Med Assoc. 1955 Jul 16;158(11):912–914. [PubMed]
- Farrar JK, Jones JV, Graham DI, Strandgaard S, MacKenzie ET. Evidence against cerebral vasospasm during acutely induced hypertension. Brain Res. 1976 Mar 5;104(1):176–180. [PubMed]
- FEIGIN I, PROSE P. Hypertensive fibrinoid arteritis of the brain and gross cerebral hemorrhage: a form of "hyalinosis". Arch Neurol. 1959 Jul;1:98–110. [PubMed]
- Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol. 1968 Dec 18;12(1):1–15. [PubMed]
- Goldman AI, Steele BW, Schnaper HW, Fitz AE, Frohlich ED, Perry HM., Jr Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension. JAMA. 1980 Oct 10;244(15):1691–1695. [PubMed]
- Gudbrandsson T, Hansson L, Herlitz H, Andrén L. Malignant hypertension--improving prognosis in a rare disease. Acta Med Scand. 1979;206(6):495–499. [PubMed]
- Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med. 1980 Nov;69(5):725–732. [PubMed]
- Jones DB. Arterial and glomerular lesions associated with severe hypertension. Light and electron microscopic studies. Lab Invest. 1974 Oct;31(4):303–313. [PubMed]
- Koch KM, Aynedjian HS, Bank N. Effect of acute hypertension on sodium reabsorption by the proximal tubule. J Clin Invest. 1968 Jul;47(7):1696–1709. [PubMed]
- Leren P, Foss PO, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG. Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet. 1980 Jul 5;2(8184):4–6. [PubMed]
- Lowenstein J, Beranbaum ER, Chasis H, Baldwin DS. Intrarenal pressure and exaggerated natriuresis in essential hypertension. Clin Sci. 1970 Mar;38(3):359–374. [PubMed]
- Lundin SA, Hallbäck-Nordlander MI. Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats. J Hypertens. 1984 Feb;2(1):11–18. [PubMed]
- Mroczek WJ, Davidov M, Gavrilovich L, Finnerty FA., Jr The value of aggressive therapy in the hypertensive patient with azotemia. Circulation. 1969 Dec;40(6):893–904. [PubMed]
- Strandgaard S, MacKenzie ET, Sengupta D, Rowan JO, Lassen NA, Harper AM. Upper limit of autoregulation of cerebral blood flow in the baboon. Circ Res. 1974 Apr;34(4):435–440. [PubMed]
- Waal-Manning HJ, Simpson FO. Beta-blockers and lipid metabolism. Br Med J. 1977 Sep 10;2(6088):705–705. [PubMed]
- Wollam GL, Hall WD, Porter VD, Douglas MB, Unger DJ, Blumenstein BA, Cotsonis GA, Knudtson ML, Felner JM, Schlant RC. Time course of regression of left ventricular hypertrophy in treated hypertensive patients. Am J Med. 1983 Sep 26;75(3A):100–110. [PubMed]
|
